NCT06213376Completed
MIT Intensive Treatment Study
Intensive MIT Paired With Video Feedback for Motor Speech Disorders and Aphasia
Source: ClinicalTrials.gov · Last updated 30 Aug 2024
Brief summary (registry, in English)
This study is examining the use of intensive melodic intonation therapy and video feedback as a means of aiding individuals with nonfluent aphasia and co-occurring motor speech impairments. Individuals with nonfluent aphasia have difficulty with language, particularly with word retrieval.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1 (actual)
- First submitted
- 9 Jan 2024
- Start date
- 28 Dec 2023
- Primary completion date
- 23 Feb 2024
- Lead sponsor
- Nevada State University
- Diseases
- Stroke
- NCT number
- NCT06213376
What you commit to
- Study type: Interventional
- Participants enrolled: 1
- From 28 Dec 2023 to the primary completion date, 23 Feb 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- • History of learning disability prior to accident (per patient report)
- Uncorrected auditory or visual impairments
- Not meeting the criteria of stroke
- Failure to provide evidence of stroke diagnosis (medical record history)
- History of psychiatric disorder
Who the study is looking for
- Fluent English speakers
- Sustained a left-hemisphere stroke
- Presents with language and motor speech impairments
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nevada State University Coordinator of this site? Confirm its status | Henderson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.